STRO
Sutro Biopharma
$9.29
+$0.42 (+4.74%)Oct 28, 2026
Key metrics
The numbers that frame STRO today
- Market cap
- $154.04M
- Gross margin
- 100%
- EV / Sales
- 2.4
- ROIC
- -205.7%
- Div yield
- 0%
- 52wk Low
- $7.15
- 52wk High
- $43.85
Growth
Revenue and earnings trend for STRO
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about STRO
Is Sutro Biopharma a good buy?
No. Sutro Biopharma has weak quality and weak momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Sutro Biopharma is selling at a very high price.
What is the market capitalization of STRO?
Sutro Biopharma's market capitalization is $154.04M.
What is the 52-week high for STRO stock?
The 52-week high for Sutro Biopharma is $43.85. The current close of $9.29 is 78.8% below that high.
What is the 52-week low for STRO stock?
The 52-week low for Sutro Biopharma is $7.15. The current close of $9.29 is 29.9% above that low.
Does STRO stock pay dividends?
Sutro Biopharma does not currently show a dividend per share in the company data.